Biocells (Beijing) Biotechnology Co., Ltd. announced that it has raised tens of millions of yuan in a round of funding led by new investor, Green Pine Capital Partners Co., Ltd. on October 31, 2023. The transaction also included participation from new investors, Xiamen Gaoxin Kechuang Angel Venture Capital Co., Ltd. and ChengDu ShengNuo Biotec Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.13 CNY | +1.82% | -1.45% | -10.89% |
May. 07 | Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection | MT |
Apr. 22 | ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.89% | 389M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 688117 Stock
- News ChengDu ShengNuo Biotec Co.,Ltd.
- Biocells Biotechnology Co., Ltd. announced that it has received funding from ChengDu ShengNuo Biotec Co.,Ltd., Xiamen Gaoxin Kechuang Angel Venture Capital Co., Ltd., Green Pine Capital Partners Co., Ltd.